Cisplatin resistance is involved with GPR30-mediated epithelial-mesenchymal transition in gastric ca

来源 :2019中国肿瘤学大会 | 被引量 : 0次 | 上传用户:klwxm
下载到本地 , 更方便阅读
声明 : 本文档内容版权归属内容提供方 , 如果您对本文有版权争议 , 可与客服联系进行内容授权或下架
论文部分内容阅读
  Objective Cisplatin is the major chemotherapeutic drug in gastric cancer,especially for advanced gastric cancer.The tumor cells often develop resistance to chemotherapeutic drugs,which seriously affects the efficacy of chemotherapy for gastric cancer.
其他文献
Objective With an incidence of 7,000±8,000 new cases per year worldwide,retinoblastoma(RB)is the most common primary intraocular malignant tumor in children.
会议
Objective Tob1,a member of Tob/BTG antiproliferative protein family,behaves as a tumor suppressor in many cancers,but its roles remains largely unknown.
会议
目的 肺癌的发病率和死亡率均居首位。近些年来,用于肿瘤的诊疗一体化研究引起广泛重视。大量研究表明,实体瘤由于肿瘤细胞的快速增殖、血管发育不完全而引起肿瘤内乏氧,导致缺氧相关性药物抵抗,从而使癌症治疗失败。
Objective Gastric cancer(GC)is the second leading cause of cancer-related deaths in China.As a small GTP-binding protein that belongs to an ARF protein subfamily,ARL4C is proposed to play a transducti
目的 甲状腺癌(thyroid carcinoma,TC)是最常见的内分泌恶性肿瘤。蛋白激酶A(protein kinase A,PKA)参与多种细胞的生物学调控。环化腺核苷一磷酸(Cyclic Adenosine monophosphate,cAMP)在真核生物中的主要功能是激活cAMP 依赖性蛋白激酶(PKA)。
目的 当前脑胶质瘤的诊断主要还是依赖各个单位的病理科诊断结果,按照中枢神经系统肿瘤的WHO 指南,脑胶质瘤的诊断需要综合病理结果和分子检测结果,因此,我们现在对脑胶质瘤的诊断不再单独依赖病理结果,而是将肿瘤标本进行全基因检测,根据检测结果指导术后精准治疗。
Objective The insulin receptor gene(INSR)undergoes alternative splicing to give rise to two functionally related but also distinct isoforms IR-A and IR-B,which dictate proliferative and metabolic regu
Objective Diffuse gliomas are the most common type of primary brain tumors in central nervous system(CNS),according to the 2016 WHO classification of CNS tumors,diffuse gliomas are generally categoriz
Objective Breast cancer is a major cancer type in women.Protein Kinase D(PKD)family,a family of serine/threonine kinases,includes three family members of PKD1,PKD2 and PKD3.
目的 探究m6A 甲基化修饰机制在弥漫大B 细胞淋巴瘤(diffuse large B cell lymphoma,DLBCL)中的重要性.方法 1.基因芯片筛选出预后良好的和预后不良的DLBCL 患者间差异表达的piRNAs;评价piRNA 在DLBCL 预后中的价值并完善预后模型.